Medicare yesterday expanded eligibility for lung cancer screening with low dose computed tomography by lowering the starting age for screening from 55 to 50 and reducing the tobacco smoking history from at least 30 packs per year to at least 20 packs per year. The final national coverage decision also simplifies requirements for the counseling and shared decision-making visit; removes the requirement for the reading radiologist to document participation in continuing medical education; and adds back a requirement for radiology imaging facilities to use a standardized lung nodule identification, classification and reporting system, the Centers for Medicare & Medicaid Services said. Low dose computed tomography is the only recommended screening test for lung cancer. 
 

Related News Articles

Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
A House Dear Colleague letter calling on House leadership to address scheduled Medicaid Disproportionate Share Hospital payment cuts received signatures from…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
The Centers for Medicare & Medicaid Services Nov. 26 proposed changes to the Medicare Advantage and prescription drug programs for contract year 2026.…
Headline
The AHA commented Nov. 26 on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system interim final action on revising…